DRMA · trading date Oct 9, 2026 · previous close $1.05 · source: Alpaca (IEX feed, not consolidated full-market data).
Key Financials
Revenue
—
Net income
-$7.56M
Total assets
$7.86M
Total liabilities
$1.64M
Stockholders' equity
$6.22M
Cash & equivalents
$7.52M
Operating income
-$7.77M
Operating cash flow
-$7.76M
Capital expenditures
—
Fiscal year 2025, via 10-K filed 2026-03-26.
A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
20.9%
Equity / assets
79.1%
CapEx / revenue
—
Operating cash flow / net income
1.03×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
San Diego, CA 92130
3525 DEL MAR HEIGHTS RD., #322
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:19 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.